BAYER HEALTHCARE vs Boehringer Ingelheim Pharmaceuticals, Inc.: FDA Enforcement Comparison

Boehringer Ingelheim Pharmaceuticals, Inc. has been the subject of 2 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for BAYER HEALTHCARE.

BAYER HEALTHCARE: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Boehringer Ingelheim Pharmaceuticals, Inc.: 0 warning letters, 2 recalls, 0 approval records, 0 Form 483s.

Side by side

BAYER HEALTHCARE — Warning letters0

Boehringer Ingelheim Pharmaceuticals, Inc. — Warning letters0

BAYER HEALTHCARE — Recalls0

Boehringer Ingelheim Pharmaceuticals, Inc. — Recalls2

BAYER HEALTHCARE — Approval records1

Boehringer Ingelheim Pharmaceuticals, Inc. — Approval records0

BAYER HEALTHCARE — Form 483s0

Boehringer Ingelheim Pharmaceuticals, Inc. — Form 483s0

Timeline

BAYER HEALTHCARE

Most recent FDA action: June 12, 2026

Full history →

Boehringer Ingelheim Pharmaceuticals, Inc.

Most recent FDA action: July 8, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"BAYER HEALTHCARE vs Boehringer Ingelheim Pharmaceuticals, Inc.: FDA Enforcement Comparison." Argus HQ, accessed August 29, 2026. https://argushq.ai/compare/bayer-healthcare-vs-boehringer-ingelheim-pharmaceuticals-inc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗